Filing Flows › Omega Healthcare Investors (OHI) › Q3 2026 › vs Q2 2026
Omega Healthcare Investors (OHI) Q3 2026 vs Q2 2026 (quarter over quarter)
Omega Healthcare Investors's revenue rose $12.3M (+4%) from $328M in Q2 2026 to $341M in Q3 2026. Operating margin 97.4% against 100.8% (-3.4 pts).
Omega Healthcare Investors, Q3 2026: revenue $341M (+9% year over year), operating margin 97.4%, net earnings $83.1M, operating cash flow $191M. The chart draws each line against Q2 2026, the increases inside each band.
Margins
| Q3 2026 | Q2 2026 | Change | |
|---|---|---|---|
| Operating margin | 97.4% | 100.8% | -3.4 pts |
| Net margin | 24.4% | 110.5% | -86.1 pts |
| Free cash flow margin | 48.9% | 60.9% | -12.0 pts |
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $341M | $328M | $12.3M | +4% |
| Operating profit | $332M | $331M | $771K | +0.2% |
| Costs & expenses | $8.9M | $0 | $8.9M | — |
| Pre-tax earnings | $89.7M | $384M | −$295M | -77% |
| Other expense, net | $242M | −$53.4M | $295M | — |
| Net earnings | $83.1M | $363M | −$280M | -77% |
| Minority interests | $3.7M | $16.8M | −$13.1M | -78% |
| Income tax | $2.8M | $4.6M | −$1.8M | -39% |
| Depreciation & amortization | $82.0M | $81.8M | $191K | +0.2% |
| Share-based compensation | $23.7M | $23.5M | $243K | +1% |
| Working capital & other | $2.2M | −$250M | $253M | — |
| Operating cash flow | $191M | $218M | −$26.7M | -12% |
| Free cash flow (OCF − capex) | $166M | $200M | −$33.4M | -17% |
| Capital expenditures | $24.6M | $17.9M | $6.7M | +37% |
Questions
How much did Omega Healthcare Investors's revenue grow quarter over quarter in Q3 2026?
Omega Healthcare Investors's revenue rose $12.3M (+4%) from $328M in Q2 2026 to $341M in Q3 2026. Operating margin 97.4% against 100.8% (-3.4 pts).